NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Remedy Meds

Remedy Meds

Private
Summit, New JerseyHealthcare & Life Scienceshttps://remedymeds.com/

Last Round

Series A

Jun 11, 2026

Total Funding Raised

$22.9M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Remedy Meds is a healthtech company that provides a consumer virtual-care and pharmacy platform focusing on medical weight loss treatments and other specialty care areas.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

weight loss medicationtelehealthGLP-1subscription healthcareweight loss subscriptionprior authorizationmetabolic healthDTC telehealthmedication fulfillmentonline pharmacyweight loss clinicdigital health platformsemaglutide

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Remedy Meds Comps

Public and private peers based on sector, stage, and business model.

Remedy Meds comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Remedy Meds Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 11, 2026
SeedNov 14, 2025

Key People

Founding team and executive leadership

Haris Memon

Founder CEO

Founding Team

Yousef Janajri

Chief Technology Officer

Executive Team

Remedy Meds Investors

Notable investors and investment history

Remedy Meds investors
InvestorRounds
Norwest Venture PartnersSeries A
L CattertonSeries A
Alpha PartnersSeed
Dynamism CapitalSeed
Gurtin VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 11, 2026

    $20M round led by L Catterton

  • Nov 14, 2025

    $3M round with Gurtin Ventures and Alpha Partners

Remedy Meds Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Remedy Meds Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Remedy Meds's valuation, stock price, and market status.

Firmographic Details

HeadquartersSummit, New Jersey
Employee Range164
Year Founded2024
Last FundingJun 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.